Global and Region Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapymarket, defines the market attractiveness level of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy industry, describes the types of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market and the development prospects and opportunities of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market in Chapter 13.

    By Player:

    • Bristol Myers Squibb

    • Pfizer

    • CARSGEN Therapeutics?Ltd

    • Guangzhou Xiangxue Pharmaceutical

    • Carina Biotech

    • Sorrento Therapeutics

    • Kite Pharma

    • Juno Therapeutics

    • Legend Biotech

    • Novartis

    • Atara Biotherapeutics

    By Type:

    • Allogeneic CAR T-Cells

    • Autologous CAR T-Cells

    By End-User:

    • Hospital

    • Diagnostic Center

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis and Outlook to 2022

    • 7.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)

    • 7.2 United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)

    • 7.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)

    • 7.4 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)

    • 7.5 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)

    • 7.6 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)

    • 7.7 South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption (2017-2022)

    8 Region and Country-wise Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Analysis and Outlook to 2028

    • 8.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)

    • 8.2 United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)

    • 8.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)

    • 8.4 China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)

    • 8.5 Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)

    • 8.6 India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)

    • 8.7 South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast (2022-2028)

    9 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Outlook by Types and Applications to 2022

    • 9.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Allogeneic CAR T-Cells Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Autologous CAR T-Cells Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diagnostic Center Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Outlook by Types and Applications to 2028

    • 10.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Allogeneic CAR T-Cells Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Autologous CAR T-Cells Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Diagnostic Center Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Competitive Analysis

    • 14.1 Bristol Myers Squibb

      • 14.1.1 Bristol Myers Squibb Company Details

      • 14.1.2 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • 14.2 Pfizer

      • 14.2.1 Pfizer Company Details

      • 14.2.2 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • 14.3 CARSGEN Therapeutics?Ltd

      • 14.3.1 CARSGEN Therapeutics?Ltd Company Details

      • 14.3.2 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • 14.4 Guangzhou Xiangxue Pharmaceutical

      • 14.4.1 Guangzhou Xiangxue Pharmaceutical Company Details

      • 14.4.2 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • 14.5 Carina Biotech

      • 14.5.1 Carina Biotech Company Details

      • 14.5.2 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • 14.6 Sorrento Therapeutics

      • 14.6.1 Sorrento Therapeutics Company Details

      • 14.6.2 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • 14.7 Kite Pharma

      • 14.7.1 Kite Pharma Company Details

      • 14.7.2 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • 14.8 Juno Therapeutics

      • 14.8.1 Juno Therapeutics Company Details

      • 14.8.2 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • 14.9 Legend Biotech

      • 14.9.1 Legend Biotech Company Details

      • 14.9.2 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • 14.10 Novartis

      • 14.10.1 Novartis Company Details

      • 14.10.2 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • 14.11 Atara Biotherapeutics

      • 14.11.1 Atara Biotherapeutics Company Details

      • 14.11.2 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy

    • Figure Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Picture

    • Table Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption by Country (2017-2022)

    • Figure United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)

    • Table Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast by Country (2022-2028)

    • Figure United States Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Allogeneic CAR T-Cells Consumption and Growth Rate (2017-2022)

    • Figure Global Autologous CAR T-Cells Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Center Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Allogeneic CAR T-Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autologous CAR T-Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Center Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Export by Region (Top 5 Countries) (2017-2028)

    • Table Bristol Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • Table CARSGEN Therapeutics?Ltd (Foundation Year, Company Profile and etc.)

    • Table CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table CARSGEN Therapeutics?Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • Table Guangzhou Xiangxue Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • Table Carina Biotech (Foundation Year, Company Profile and etc.)

    • Table Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • Table Sorrento Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • Table Kite Pharma (Foundation Year, Company Profile and etc.)

    • Table Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • Table Juno Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • Table Legend Biotech (Foundation Year, Company Profile and etc.)

    • Table Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service

    • Table Atara Biotherapeutics (Foundation Year, Company Profile and etc.)

    • Table Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.